Michael Pourdehnad

Company: Bristol Myers Squibb
Job title: VP, Early Clinical Development, Hematology/Oncology & Cell Therapy
Bio:
Seminar: Clinical Activity of Novel Celmod CC-99282 in Patients with Non-Hodgkin Lymphoma
For more information on this session, please download the full event guide.
Day: Day One